200 related articles for article (PubMed ID: 22562654)
41. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
42. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice.
Singh M; Sétáló G; Guan X; Frail DE; Toran-Allerand CD
J Neurosci; 2000 Mar; 20(5):1694-700. PubMed ID: 10684871
[TBL] [Abstract][Full Text] [Related]
43. Phosphorylation of serine 212 confers novel activity to human estrogen receptor α.
Shindo S; Sakuma T; Negishi M; Squires J
Steroids; 2012 Apr; 77(5):448-53. PubMed ID: 22266331
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms of Gefitinib-mediated reversal of tamoxifen resistance in MCF-7 breast cancer cells by inducing ERα re-expression.
Zhang X; Zhang B; Liu J; Liu J; Li C; Dong W; Fang S; Li M; Song B; Tang B; Wang Z; Zhang Y
Sci Rep; 2015 Feb; 5():7835. PubMed ID: 25644501
[TBL] [Abstract][Full Text] [Related]
45. Estrogen receptor-alpha predominantly mediates the salutary effects of 17beta-estradiol on splenic macrophages following trauma-hemorrhage.
Suzuki T; Shimizu T; Yu HP; Hsieh YC; Choudhry MA; Bland KI; Chaudry IH
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C978-84. PubMed ID: 17553937
[TBL] [Abstract][Full Text] [Related]
46. The sequence Pro295-Thr311 of the hinge region of oestrogen receptor α is involved in ERK1/2 activation via GPR30 in leiomyoma cells.
Leiber D; Burlina F; Byrne C; Robin P; Piesse C; Gonzalez L; Leclercq G; Tanfin Z; Jacquot Y
Biochem J; 2015 Nov; 472(1):97-109. PubMed ID: 26371374
[TBL] [Abstract][Full Text] [Related]
47. Estrogen receptor-alpha overexpression suppresses 17beta-estradiol-mediated vascular endothelial growth factor expression and activation of survival kinases.
Bake S; Ma L; Sohrabji F
Endocrinology; 2008 Aug; 149(8):3881-9. PubMed ID: 18450951
[TBL] [Abstract][Full Text] [Related]
48. Phospho-serine-118 estrogen receptor-alpha detection in human breast tumors in vivo.
Murphy L; Cherlet T; Adeyinka A; Niu Y; Snell L; Watson P
Clin Cancer Res; 2004 Feb; 10(4):1354-9. PubMed ID: 14977836
[TBL] [Abstract][Full Text] [Related]
49. 17beta-estradiol induces the translocation of the estrogen receptors ESR1 and ESR2 to the cell membrane, MAPK3/1 phosphorylation and proliferation of cultured immature rat Sertoli cells.
Lucas TF; Siu ER; Esteves CA; Monteiro HP; Oliveira CA; Porto CS; Lazari MF
Biol Reprod; 2008 Jan; 78(1):101-14. PubMed ID: 17928626
[TBL] [Abstract][Full Text] [Related]
50. Ligand-independent activation of oestrogen receptor alpha by caveolin-1.
Schlegel A; Wang C; Pestell RG; Lisanti MP
Biochem J; 2001 Oct; 359(Pt 1):203-10. PubMed ID: 11563984
[TBL] [Abstract][Full Text] [Related]
51. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
[TBL] [Abstract][Full Text] [Related]
52. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
Filardo EJ; Quinn JA; Bland KI; Frackelton AR
Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
[TBL] [Abstract][Full Text] [Related]
53. Signal pathway of 17beta-estradiol-induced MUC5B expression in human airway epithelial cells.
Choi HJ; Chung YS; Kim HJ; Moon UY; Choi YH; Van Seuningen I; Baek SJ; Yoon HG; Yoon JH
Am J Respir Cell Mol Biol; 2009 Feb; 40(2):168-78. PubMed ID: 18688042
[TBL] [Abstract][Full Text] [Related]
54. Prostaglandin E2 induces CYP1B1 expression via ligand-independent activation of the ERalpha pathway in human breast cancer cells.
Han EH; Kim HG; Hwang YP; Song GY; Jeong HG
Toxicol Sci; 2010 Apr; 114(2):204-16. PubMed ID: 20093341
[TBL] [Abstract][Full Text] [Related]
55. GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals.
Gao F; Ma X; Ostmann AB; Das SK
Endocrinology; 2011 Apr; 152(4):1434-47. PubMed ID: 21303939
[TBL] [Abstract][Full Text] [Related]
56. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways.
Clark MJ; Harrison C; Zhong H; Neubig RR; Traynor JR
J Biol Chem; 2003 Mar; 278(11):9418-25. PubMed ID: 12524446
[TBL] [Abstract][Full Text] [Related]
57. Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteins.
Higgins KJ; Liu S; Abdelrahim M; Vanderlaag K; Liu X; Porter W; Metz R; Safe S
Mol Endocrinol; 2008 Feb; 22(2):388-402. PubMed ID: 18006642
[TBL] [Abstract][Full Text] [Related]
58. Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor.
Lecat S; Belemnaba L; Galzi JL; Bucher B
Cell Signal; 2015 Jul; 27(7):1297-304. PubMed ID: 25817573
[TBL] [Abstract][Full Text] [Related]
59. Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i).
Wyckoff MH; Chambliss KL; Mineo C; Yuhanna IS; Mendelsohn ME; Mumby SM; Shaul PW
J Biol Chem; 2001 Jul; 276(29):27071-6. PubMed ID: 11369763
[TBL] [Abstract][Full Text] [Related]
60. Extracellular signal-regulated kinase 1/2 activation by myometrial oxytocin receptor involves Galpha(q)Gbetagamma and epidermal growth factor receptor tyrosine kinase activation.
Zhong M; Yang M; Sanborn BM
Endocrinology; 2003 Jul; 144(7):2947-56. PubMed ID: 12810550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
